Abstract
Selected nationally notifiable infectious diseases reported to the Centers for Disease Control (CDC) for 1994 include (1) Lyme disease, 13,043 reported cases; (2) Rocky Mountain spotted fever, 465 cases; (3) psittacosis, 38 cases; and (4) trichinosis, 32 cases.1 Toxoplasmosis and giardiasis are highly prevalent but are not considered notifiable to the CDC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Summary of notifiable diseases, United States—October 6. MMWR 1995;43:3–80.
St. Georgiev V. Management of toxoplasmosis: practical therapeutics. Drugs 1994;48:179–88.
Holliman RE. Congenital toxoplasmosis: prevention, screening and treatment. J Hosp Infect 1995;30:179–90. [Volume 30 (Supplement)]
Winstanley P. Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome. Postgrad Med J 1995;71:404–8.
Roizen N, Swisher CN. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95:11–20.
Nussenblatt RB, Belfort R. Ocular toxoplasmosis. JAMA 1994;271:304–7.
Behbahani R, Moshfeghi M. Therapeutic approaches for AIDS-related toxoplasmosis. Ann Pharmacother 1995;29: 760–8.
McCabe R, Chirurgi V. Issues in toxoplasmosis. Parasitic Dis 1993;7:587–603.
Matsui D. Prevention, diagnosis, and treatment of fetal toxoplasmosis. Clin Perinatol 1994;21:675–89.
Compton SJ, Celum CL. Trichinosis with ventilatory failure and persistent myocarditis. Clin Infect Dis 1993;16:500–4.
MMWR. “Outbreak of trichinellosis associated with eating cougar jerky,” Idaho, 1995. 1996;45:205–6.
Mawhorter S, Kazura JW. Trichinosis of the central nervous system. Semin Neurol 1993;13:148–52.
Stack P. Trichinosis, still a public health threat. Postgrad Med 1995;97:137–44.
Kirchner JT, Boyarsky SA. Chlamydia psittaci, an uncommon cause of community-acquired pneumonia. Arch Fam Med 1993;2:997–1001.
Gherman RB, Leventis LL, Miller RC. Chlamydial psittacosis during pregnancy: a case report. Obstet Gynecol 1995; 86:648–50.
Hughes P, Chidley K, Cowie J. Neurological complications in psittacosis: a case report and literature review. Respir Med 1995;89:637–8.
Schlossberg D, Delgado J, Moore M, et al. An epidemic of avian and human psittacosis. Arch Intern Med 1993;153: 2594–6.
Davies A, Collins T. Respiratory Chlamydia: the management of an outbreak. Public Health 1995;109:207–11.
Farthing MJG. Diarrhoeal disease: current concepts and future challenges. Transact R Soc Trop Med Hyg 1993;87: 17–21.
Lewis DIM, Freedman AR. Giardia lamblia as an intestinal pathogen. Dig Dis 1992;10:102–11.
Babb RR. Giardiasis, taming this pervasive parasitic infection. Postgrad Med 1995;2:155–8.
Cook GC. Entamoeba histolytica and Giardia lamblia infections: current diagnostic strategies. Parasite 1995;2:107–12.
Gray SF, Gunnell DJ, Peters TJ. Risk factors for giardiasis: a case-control study in Avon and Somerset. Epidemiol Infect 1994;113:95–102.
Hill DR. Giardiasis, issues in diagnosis and management. Parasitic Dis 1993;7:503–25.
Lyme Disease—United States 1994. MMWR 1995;44:459–62.
Evans J. Lyme disease. Curr Opin Rheumatol 1995;7:322–8.
Khorenian SD, Lebwohl M. New cutaneous manifestations of systemic diseases. Am Fam Physician 1995;51:625–30.
Pachner AR. Early disseminated Lyme disease: Lyme meningitis. Am J Med 1995;98:4A, 30S-43S.
Halperin JJ. Neuroborreliosis. Am J Med 1995;98:4A, 52S–62S.
Sigal H. Early disseminated Lyme disease: cardiac manifestations. Am J Med 1995;98:4A, 25S-9S.
Oesch TR. Lyme borreliosis. J Tenn Med Assoc 1995;88: 131–3.
Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med 1995;98:4A, 44S-51S.
Ilowite N. Muscle, reticuloendothelial, and late skin manifestations of Lyme disease. Am J Med 1995;98:4A, 63S–8S.
Magnarelli LA. Current status of laboratory diagnosis of Lyme disease. Am J Med 1995;98:4A, 10S-14S.
Nowakowski J, Nadelman RB. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol 1995;32:223–7.
Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995;98:4A, 2S-9S.
Walker DH. Rickettsioses of the spotted fever group around the world. J Dermatol 1989;16:169–77.
Centers for Disease Control. RMSF-VS, 1990. MMWR 1991; 39:40.
Raoult D, Walker DH. Rickettsia rickettsii and other spotted fever group rickettsiae: principles and practice of infectious diseases. In Principles and Practice of Infectious Diseases, 3rd edit., edited by Mandell GL, Douglas RG, Jr., and Bennett JE. London: Churchill Livingstone, 1990, pp. 1465–71.
Kirk J, Fine DP, Sexton DJ, Muchmore HG. RMSF, a clinical review. Medicine 1990;69:35–45.
Helmick CG, Bernard KW, D’Angelo LJ. RMSF: clinical laboratory and epidemiological features of 262 cases. J Infect Dis 1984;150:480–8.
Duffy RJ, Hammer ME. Ocular manifestations of RMSF. Ann Ophthalmol 1987;19:301–6.
Kamper CA, Chessman KH, Phelps SJ. RMSF, therapy review. Clin Pharmacol 1988;7:109–16.
Walker DH. RMSF: a disease in need of microbiological concern. Clin Microbiol Rev 1989;2:227–40.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kubala, G.S. (1998). Selected Infectious Diseases. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_44
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2947-4_44
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2949-8
Online ISBN: 978-1-4757-2947-4
eBook Packages: Springer Book Archive